We're Making Changes to Our Site to Better Serve You


Newest Laws and Effective Dates

Posted on May 23, 2018

New Laws that go into effect July 1, 2018
Governor Haslam’s Opioid Reform Bill is now Public Chapter 1039
Click on this infographic to view the prescriptions requirements for different days supply and the patients and prescribers that are exempt from these requirements.
Public Chapter 1015 prohibits the “gag clauses” in PBM contracts that have prevented pharmacists from discussing lower cost options with patients.
Public Chapter 615 Authorizes pharmacists to dispense emergency situations.
Public Chapter 617 establishes that a medication therapy management program is “pharmacist-provided”.
Public Chapter 978 Buprenorphine Clinic Restrictions
SB 2258/HB 1832 has passed but has not been signed into law yet.  However, it is scheduled to become effective 7/1/2018 and will make Gabapentin a Schedule V Controlled Substance.
New Laws effective January 1, 2019
Public Chapter 838  Requires PBMs to obtain a license through the state if doing business in Tennessee
Public Chapter 1007 will allow for the Partial Filling of Controlled Substances.

End of Session Summary for Tennessee

Posted on May 01, 2018

What Passed?
PBM Licensing Through TN Dept of Commerce and Insurance (SB 1852/HB 1857)
Effective Date: January 1, 2019
Senate Sponsor(s): Haile, Crowe, Bell, Yager, Jackson, Reeves
House Sponsor(s): Powers, Matlock, Keisling, Weaver, Calfee, Terry

Requires all pharmacy benefits managers (PBMs) to obtain licensure and renew biennially through the Tennessee Department of Commerce and Insurance (TDCI)
Requires PBMs to demonstrate that they are able to transact in this state, are financially responsible, and have not had a prior license denied or revoked within five (5) years of the date the license is sought.
Requires PBMs to provide TDCI with the person or entity’s name, address, telephone number, and website address.
Requires PBMs to notify TDCI within 60 days of any change in PBM information.

5/1/2017 Illinois Update

Posted on May 01, 2017

The Illinois House Passed legislation on Friday, April 28, that would establish a task force to study pharmacy issues and set recommendations to improve consumer safety. The measure, sponsored by Reps. Mike Zalewski (D-Riverside) and Mary Flowers (D-Chicago), comes after a Chicago Tribune investigation that found more than one-half of 255 pharmacies tested in the Chicago area and nearby states did not warn customers about a potential drug interaction that could be harmful or even fatal.

The Issues

Posted on May 01, 2017

DIR Fees hurt everyone! Well almost everyone. Help educate patients and lawmakers on what these fees really do.

Mississippi Update 4/04/2017

Posted on Apr 04, 2017

A plethora of bills, that would have directly or indirectly impacted pharmacy, died in committee.  Many of these were amendments to existing acts.  A couple of the bills left us scratching our heads.  Failure on attempts to have pharmacists reimbursed for services and for partial day-supply resulting from medication-synching, were unfortunate.  However, we are hopeful that these items will be revisited in the 2018 legislature.
Here are the bills that will become law, having been signed by Governor Phil Bryant.
HB 996 Opioid antagonists; authorize standing orders to pharmacies to dispense to persons without individual prescriptions.
HB 1032 Prescription Monitoring Program; require all health care providers authorized to prescribe drugs to register with.
HB 2610 Cannabidiol; clarify use in research of seizures and other medical conditions.


Posted on Apr 04, 2017

4/03/2017    Missouri House Passes Prescription Drug Tracking Program
House members, in a vote of 102-54, have passed a bill, which if signed into law, will make Missouri the last state to adopt a prescription drug monitoring program.


Posted on Apr 03, 2017

HB 2190 has passed the Arkansas House and Senate and moves on to the Governor for signature.  If signed into law, this legislation will amend the “Arkansas Medical Marijuana Amendment of 2016.”  Some key components of the bill, are requirements that dispensaries sell vaping equipment and employee pharmacist consultants.  The bill also includes a provision to protect the pharmacist from any liability.


Posted on Feb 16, 2017

Right now the GPHA’s legislative priorities are the Pharmacy Patient Fair Practices Act and the Audit Bill of Rights – HB 206. Here is what we should do about it.